Santhera Pharmaceuticals (Schweiz) AG;The United States of America as represented by the Department of Health and Human Services
发明人:
MEIER, THOMAS,BIELEKOVA, BIBIANA,MCFARLAND, HENRY F.
申请号：
PL09795720
公开号：
PL2424513T3
申请日:
2009.12.18
申请国别(地区):
PL
年份:
2015
代理人:
摘要：
The present invention relates to pharmaceuticals and uses thereof directed to the curative treating or preventing of Primary Progressive Multiple Sclerosis (PP-MS), by using 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone) as the active agent.
